Please complete the CAPTCHA to continue
@griffinsecurities.com
✓
3 phones found area 646 and 212
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
Thomas J. Mcgahren is listed as Managing Director, Griffin Securities, Inc. at Griffin Securities, Inc., based in New York, New York, United States. AeroLeads shows a work email signal at griffinsecurities.com, phone signal with area code 646, 212, and a matched LinkedIn profile for Thomas J. Mcgahren.
Thomas J. Mcgahren previously worked as Managing Director, Investment Banking at Griffin Securities, Inc. and Member of Founding Group, Member of Scientific Advisory Board (SAB) at Agilis Biotherapeutics. Thomas J. Mcgahren holds Jd from The University Of Texas School Of Law.
This section adds company-level context without repeating Thomas J. Mcgahren's masked contact details.
AeroLeads found 1 current-domain work email signal for Thomas J. Mcgahren. Compare company email patterns before reaching out.
Experienced biotechnology investment banker, analyst, advisor, entrepreneur and investor. Currently, Managing Director, investment banking, at Griffin Securities, an entrepreneurial boutique investment bank in Manhattan advising startup, private and public biotech companies seeking financing, M&A, and strategic advisory solutions. Particularly of interest are companies with "change the world" aspirations. I leverage my significant experience as a senior biotech analyst at Merrill Lynch covering large, mid and small cap companies (ranked #1 Forbes Drugs Analyst 2008), medical and legal (MD,JD) training and experience representing pharma, biotech and med-tech companies as an attorney at a large international law firm to provide unique and comprehensive medical / scientific / legal / IP / FDA / investment / financial analysis. My experience and interests provide an edge in assessing potential investable propositions and high value-add in my interactions and work with life science companies, sell & buy side, venture capital and private equity firms. A member of the founding group and served on the SAB of Agilis Biotherapeutics (gene therapy for rare genetic CNS diseases (AADC deficiency - EMA approved, BLA pending) which was acquired by PTC Therapeutics (PTCT) in 2018. Member of the founding group of Xylocor (private, phase 2 development)(gene therapy to promote angiogenesis to reduce ischemic burden) currently in phase 2 development. Member of the founding group of MAAVRX (private, preclinical), gene therapy for severe Parkinson's disease. Specialties: investment bankingstrategic advisoryventure capitalbiotechnology synthetic biologygene therapycell therapyrare diseasesbiopharmaceuticals equity researchcompany analysisFDA practice and procedurelegal intellectual propertylicensing financingstart-ups
Listed skills include Venture Capital, Mergers And Acquisitions, Biotechnology, Valuation, and 21 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
New York, NY, US
Life sciences investment banker advising private and public biotech, pharma, spec pharma, medtech and diagnostic companies in financing, M&A and strategic matters. Leveraging diverse skill sets, unique educational background (MD, JD), bulge bracket biotech sell-side analyst experience, legal experience representing life science companies at large.
Member of founding group and Scientific Advisory Board (SAB) of Agilis Biotherapeutics, www.agilisbio.com, a biotechnology company focused on designing and engineering first-in-class gene therapy to address rare CNS diseases. (Acquired by PTC Therapeutics (PTCT) Aug. 2018). Lead candidate, AGIL-AADC is pre-BLA for the treatment of Aromatic L-Amino Acid.
Greensboro, NC, US
Assisted with assessment and due diligence of potential life sciences investment opportunities for early state VC fund formed by alumni of Colgate University. Leveraged medical, legal and Wall Street biotech analyst background.
New York, NY, US
Senior Director, Senior Biotechnology Analyst. Forbes #1 Drugs Analyst ranking 2008. Responsible for all aspects of sell-side research: due diligence, launching coverage, financial modeling, industry analysis, surveys, Merrill Lynch health conferences, marketing, roadshows, medical conferences, court hearings, deal vetting, collaboration with capital.
Charlotte, NC, US
Associate biotechnology analyst on II-ranked team covering large, mid and small cap companies. Drafted initiations, event and earnings notes. Routinely consulted by other BofA analysts, particularly on IP, FDA, medical issues in view of expertise and experience as a physician and attorney representing biotech and big pharma companies as a litigator.
Litigator representing pharmaceutical, biotechnology and med-tech companies in intellectual property, FDA and corporate matters at major international law firm. Developed expertise in biopharma industry, FDA practice & procedure and particularly biotech intellectual property litigation. Participated in all phases of litigation, counseling and business.
Quick answers generated from the profile data available on this page.
Thomas J. Mcgahren works for Griffin Securities, Inc..
Thomas J. Mcgahren is listed as Managing Director, Griffin Securities, Inc. at Griffin Securities, Inc..
AeroLeads has found 1 work email signal at @griffinsecurities.com for Thomas J. Mcgahren at Griffin Securities, Inc..
AeroLeads has found 3 phone signal(s) with area code 646, 212 for Thomas J. Mcgahren at Griffin Securities, Inc..
Thomas J. Mcgahren is based in New York, New York, United States while working with Griffin Securities, Inc..
Thomas J. Mcgahren has worked for Griffin Securities, Inc., Agilis Biotherapeutics, Chenango Capital, Merrill Lynch, and Banc Of America Securities.
You can use AeroLeads to view verified contact signals for Thomas J. Mcgahren at Griffin Securities, Inc., including work email, phone, and LinkedIn data when available.
Thomas J. Mcgahren holds Jd from The University Of Texas School Of Law.
Thomas J. Mcgahren is listed with skills including Venture Capital, Mergers And Acquisitions, Biotechnology, Valuation, Lifesciences, Financial Modeling, Investment Banking, and Biopharmaceuticals.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts